Medico Remedies Ltd (MEDICO) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 1002925, "name": "Medico Remedies", "stock_name": "Medico Remedies", "full_name": "Medico Remedies Ltd", "name_url": "stocks-analysis/medico-remedies", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "41.74", "chg": 1.05, "chgp": "2.58%", "dir": 1, "prev_price": "40.69", "mcapval": "337.00 Cr", "mcap": "Micro Cap", "scripcode": 540937, "symbol": "MEDICO", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "India SENSEX", "isin": "INE630Y01024", "curr_date": "Apr 29", "curr_time": "", "bse_nse_vol": "1.44 lacs", "exc_status": "Active", "traded_date": "Apr 29, 2026", "traded_date_str": "2026 04 29", "score": "", "scoreText": "", "Live": 1, "market_time": 1, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/medico-remedies-1002925-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Medico Remedies Ltd Downgraded to Sell Amid Bearish Technicals and Underperformance", "link": "https://www.marketsmojo.com/news/stock-recommendation/medico-remedies-ltd-downgraded-to-sell-amid-bearish-technicals-and-underperformance-3967673", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/MedicoRemediesL_mojoScore_3967673.png", "date": "2026-04-29 08:24:39", "description": "Medico Remedies Ltd has seen its investment rating downgraded from Hold to Sell as of 28 Apr 2026, driven primarily by deteriorating technical indicators despite some positive financial trends. The micro-cap pharmaceutical company’s current Mojo Score stands at 47.0, reflecting a cautious outlook amid mixed signals across quality, valuation, financial trend, and technical parameters." }, { "title": "Medico Remedies Ltd Upgraded to Hold as Technicals Improve and Financials Strengthen", "link": "https://www.marketsmojo.com/news/stock-recommendation/medico-remedies-ltd-upgraded-to-hold-as-technicals-improve-and-financials-strengthen-3958593", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/MedicoRemediesL_mojoScore_3958593.png", "date": "2026-04-23 08:23:40", "description": "Medico Remedies Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Sell to Hold as of 22 April 2026. This change reflects a nuanced improvement across technical indicators, valuation metrics, financial trends, and overall company quality, signalling a cautious but positive outlook for investors amid mixed long-term performance." }, { "title": "Medico Remedies Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/medico-remedies-ltd-is-rated-sell-3944503", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/MedicoRemediesL_mojoScore_3944503.png", "date": "2026-04-13 10:10:45", "description": "Medico Remedies Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 13 April 2026, providing investors with the most up-to-date view of the company’s performance and outlook." }, { "title": "Medico Remedies Gains 13.27%: Key Valuation and Rating Shifts Shape the Week", "link": "https://www.marketsmojo.com/news/stocks-in-action/medico-remedies-gains-1327-key-valuation-and-rating-shifts-shape-the-week-3931881", "imagepath": "", "date": "2026-04-04 13:02:39", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>30 Mar:</strong> Stock hits 52-week low at Rs.31 amid market downturn</p>\n <p><strong>30 Mar:</strong> MarketsMOJO upgrades rating to Hold citing improved valuation</p>\n <p><strong>30 Mar:</strong> Valuation metrics shift to attractive, signalling price appeal</p>\n <p><strong>2 Apr:</strong> Downgrade to Sell issued despite recent profit growth</p>\n <p><strong>2 Apr:</strong> Week closes at Rs.37.81, up 13.27% vs Sensex down 0.29%</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.3..." }, { "title": "Medico Remedies Downgraded to Sell Amid Mixed Financials and Valuation Shift", "link": "https://www.marketsmojo.com/news/stock-recommendation/medico-remedies-downgraded-to-sell-amid-mixed-financials-and-valuation-shift-3929697", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/MedicoRemediesL_mojoScore_3929697.png", "date": "2026-04-02 08:32:29", "description": "Medico Remedies Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell despite an upgrade in its valuation grade from fair to attractive. This shift, effective from 1 April 2026, reflects a complex interplay of factors including valuation metrics, financial trends, quality assessments, and technical indicators, which together paint a nuanced picture for investors." }, { "title": "Five Consecutive Losses Push Medico Remedies Ltd to a New 52-Week Low", "link": "https://www.marketsmojo.com/news/stocks-in-action/medico-remedies-ltd-falls-to-52-week-low-of-rs31-amid-market-downturn-3925341", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/MedicoRemediesL_priceRelatedfactors_3925341.png", "date": "2026-03-30 14:30:34", "description": "For the fifth consecutive session, Medico Remedies Ltd has closed lower, culminating in a fresh 52-week low of Rs 31 on 30 Mar 2026. This decline comes amid a broader market downturn, but the stock's underperformance is notably sharper than its sector peers." }, { "title": "Medico Remedies Ltd Upgraded to Hold as Valuation and Financials Improve", "link": "https://www.marketsmojo.com/news/stock-recommendation/medico-remedies-ltd-upgraded-to-hold-as-valuation-and-financials-improve-3923541", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/MedicoRemediesL_mojoScore_3923541.png", "date": "2026-03-30 08:11:01", "description": "Medico Remedies Ltd has seen its investment rating upgraded from Sell to Hold as of 27 March 2026, reflecting a marked improvement in valuation metrics and financial performance despite recent share price weakness. The pharmaceutical company’s enhanced score is driven primarily by a shift to an attractive valuation grade, supported by robust return on capital employed (ROCE), steady financial trends, and a cautiously optimistic technical outlook." }, { "title": "Medico Remedies Ltd Valuation Shifts Signal Renewed Price Attractiveness", "link": "https://www.marketsmojo.com/news/stocks-in-action/medico-remedies-ltd-valuation-shifts-signal-renewed-price-attractiveness-3923375", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/MedicoRemediesL_valuationdot_3923375.png", "date": "2026-03-30 08:01:50", "description": "Medico Remedies Ltd has witnessed a notable shift in its valuation parameters, moving from a fair to an attractive rating, reflecting a more compelling price proposition for investors. Despite recent share price declines, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now suggest improved relative value compared to historical levels and peer benchmarks within the Pharmaceuticals & Biotechnology sector." }, { "title": "Medico Remedies Ltd Falls to 52-Week Low of Rs 33.78 as Sell-Off Deepens", "link": "https://www.marketsmojo.com/news/stocks-in-action/medico-remedies-ltd-falls-to-52-week-low-amid-continued-market-pressure-3919997", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/MedicoRemediesL_priceRelatedfactors_3919997.png", "date": "2026-03-27 14:46:03", "description": "A sharp decline in Medico Remedies Ltd has pushed the stock to a fresh 52-week low of Rs 33.78 on 27 Mar 2026, marking a significant 6.22% intraday drop amid broader market weakness. This latest fall extends the stock’s losing streak to two consecutive sessions, reflecting persistent selling pressure despite the company’s recent positive financial results." } ], "total": 182, "sid": "1002925", "stock_news_url": "https://www.marketsmojo.com/news/medico-remedies-1002925" }, "announcements": [ { "caption": "Intimation Of Action Taken Or Order Passed By Regulatory Statutory Enforcement Authority Or Judicial Body Under Regulation 30 (Read With Part B Of Schedule III) (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations)", "datetime": "16-Apr-2026", "details": "Please find enclosed", "source": "BSE" }, { "caption": "Clarification With Regards To Additional Details Sought In Respect Of Outcome Of Board Meeting Held On 18Th February 2026 Submitted To Exchange On 18Th February 2026", "datetime": "24-Feb-2026", "details": "Please find enclosed", "source": "BSE" }, { "caption": "Intimation Of Action Taken Or Order Passed By Regulatory Statutory Enforcement Authority Or Judicial Body Under Regulation 30 (Read With Part B Of Schedule III) (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations)", "datetime": "24-Feb-2026", "details": "Please find enclosed", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "No <strong>Dividend</strong> history available", "data": [] }, { "img": "splits.svg", "title": "SPLITS", "msg": "", "data": [ { "txt": "Medico Remedies Ltd has announced <strong>2:10</strong> stock split, ex-date: 16 Mar 23", "dt": "2023-03-16", "middle_text": "Split" } ] }, { "img": "bonus.svg", "title": "BONUS", "msg": "", "data": [ { "txt": "Medico Remedies Ltd has announced <strong>3:1</strong> bonus issue, ex-date: 16 Nov 21", "dt": "2021-11-16", "middle_text": "Bonus Alert" } ] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

30 Mar: Stock hits 52-week low at Rs.31 amid market downturn

30 Mar: MarketsMOJO upgrades rating to Hold citing improved valuation

30 Mar: Valuation metrics shift to attractive, signalling price appeal

2 Apr: Downgrade to Sell issued despite recent profit growth

2 Apr: Week closes at Rs.37.81, up 13.27% vs Sensex down 0.29%

Week Open

Rs.3...

Read full news article

Medico Remedies Downgraded to Sell Amid Mixed Financials and Valuation Shift

2026-04-02 08:32:29

Medico Remedies Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell despite an upgrade in its valuation grade from fair to attractive. This shift, effective from 1 April 2026, reflects a complex interplay of factors including valuation metrics, financial trends, quality assessments, and technical indicators, which together paint a nuanced picture for investors.

Read full news article

Five Consecutive Losses Push Medico Remedies Ltd to a New 52-Week Low

2026-03-30 14:30:34

For the fifth consecutive session, Medico Remedies Ltd has closed lower, culminating in a fresh 52-week low of Rs 31 on 30 Mar 2026. This decline comes amid a broader market downturn, but the stock's underperformance is notably sharper than its sector peers.

Read full news article

Medico Remedies Ltd Upgraded to Hold as Valuation and Financials Improve

2026-03-30 08:11:01

Medico Remedies Ltd has seen its investment rating upgraded from Sell to Hold as of 27 March 2026, reflecting a marked improvement in valuation metrics and financial performance despite recent share price weakness. The pharmaceutical company’s enhanced score is driven primarily by a shift to an attractive valuation grade, supported by robust return on capital employed (ROCE), steady financial trends, and a cautiously optimistic technical outlook.

Read full news article

Medico Remedies Ltd Valuation Shifts Signal Renewed Price Attractiveness

2026-03-30 08:01:50

Medico Remedies Ltd has witnessed a notable shift in its valuation parameters, moving from a fair to an attractive rating, reflecting a more compelling price proposition for investors. Despite recent share price declines, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now suggest improved relative value compared to historical levels and peer benchmarks within the Pharmaceuticals & Biotechnology sector.

Read full news article

Medico Remedies Ltd Falls to 52-Week Low of Rs 33.78 as Sell-Off Deepens

2026-03-27 14:46:03

A sharp decline in Medico Remedies Ltd has pushed the stock to a fresh 52-week low of Rs 33.78 on 27 Mar 2026, marking a significant 6.22% intraday drop amid broader market weakness. This latest fall extends the stock’s losing streak to two consecutive sessions, reflecting persistent selling pressure despite the company’s recent positive financial results.

Read full news article